Roy and Ramancha were indicted in a transnational counterfeit Ozempic scheme.

An indictment is a charging document. It is not a conviction. On Tuesday, Sept. 29, 2026, the Justice Department announced that a Middle District of Florida grand jury charged the pair in an alleged transnational counterfeit Ozempic distribution scheme. Roy appeared in Tampa after extradition from Italy. A statutory maximum of 71 years if convicted is exposure. It is not a sentence.

According to the Justice Department, beginning at least in July 2023 and continuing to April 2024, Roy and Ramancha allegedly obtained counterfeit Ozempic from unauthorized sources in China and sold it to U.S. distributors at deeply discounted prices. The indictment alleges counterfeit packaging, package inserts, pen labels, and needles meant to deceive customers into believing the products were authentic manufacturer-authorized Ozempic. The department said the scheme continued even after an FDA seizure in December 2023 and a public warning. Those are charging allegations. They are not findings.

The pair face one count of conspiracy to commit smuggling and to defraud the United States, three counts of smuggling, and two counts of selling counterfeit drugs and holding counterfeit drugs for sale. FDA’s Office of Criminal Investigations is investigating. An indictment remains an accusation until a jury or plea resolves it. All defendants are presumed innocent until proven guilty in a court of law.